News
-
PPI claims next week
Tuesday | Mar 28 2017THE Pharmacy Guild of Australia reminds pharmacists that claiming for Pharmacy Practice Incentives (PPI) Clinical Interventions and Dose Administration Aids for the 01 Jan to 31 Mar 2017 period is available from 01 Apr to 14 Apr via the 6CPA Registration and Claiming Portal at 6cpa.com.au.
-
Hospital pharmacists have GRIT
Tuesday | Mar 28 2017THE Society of Hospital Pharmacists of Australia has released the first edition of its new quarterly journal, titled Pharmacy Growth, Research, Innovation and Training (GRIT).
-
Apr price disclosure hits
Tuesday | Mar 28 2017THE government has hailed the impact that PBS reform is having on consumers' hip pockets, announcing that the cost of more than 1100 medicine brands will be reduced from next month.
-
Weekly Comment 27 Mar 17: How to become a ‘FITTER Pharmacist’
Monday | Mar 27 2017This week's contributor is Teresa Di Franco, Pharmacist and Credentialled Diabetes Educator, Perth Diabetes Care.
-
Dispensary Corner 27 Mar 17
Monday | Mar 27 2017UNITED States customs officials last week seized more than 40,000 counterfeit condoms which were being imported into Puerto Rico from China.
-
Menveo shortage
Monday | Mar 27 2017GLAXOSMITHKLINE has advised of a short-term supply constraint of its Menveo meningococcal ACWY vaccine, after a recent increase in notifications which is driving additional demand.
-
Paramedics to be regulated by AHPRA
Monday | Mar 27 2017THE Council of Australian Governments Health Council has considered a major revision to the Health Practitioner Regulation National Law, with a draft Bill proposing a range of reforms including the addition of paramedics to the national registration scheme.
-
J&J pulls YouTube ads
Monday | Mar 27 2017JOHNSON & Johnson has announced it will suspend all of its digital advertising on YouTube, due to concerns that its products may be appearing alongside offensive content on the Google-owned video sharing platform.
-
New cancer drug nod
Monday | Mar 27 2017THE US Food and Drug Administration FDA today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC).
-
PBS rejects Keytruda
Monday | Mar 27 2017KEYTRUDA has failed to receive a pharmaceutical Benefits Scheme (PBS) listing due to concerns from the PBAC around the incremental cost-effectiveness ratio (ICER) per quality-adjusted life-year (QALY).